Kintara Therapeutics to Participate in the Fifth Annual Glioblastoma Awareness Day in Washington, D.C.

Kintara Therapeutics, a biopharmaceutical company specializing in the development of treatments for solid tumor cancers, will be participating in the fifth annual Glioblastoma Awareness Day in Washington, D.C. This event aims to raise awareness and support for research advancements in glioblastoma (GBM). Kintara's leading treatment candidate for GBM, VAL-083, is currently being evaluated in the ..